Ureteroscopy pp 331-339 | Cite as

Laser Applications, Tumor, and Stricture

  • Adam B. ShrewsberryEmail author
  • Daniel J. Canter
  • Kenneth Ogan
Part of the Current Clinical Urology book series (CCU)


With improvements in technique and equipment, endoscopic treatment of both transitional cell carcinoma of the upper urinary tract and ureteral stricture disease has become more feasible. Patients with upper tract urothelial carcinoma who have bilateral disease, a solitary kidney, renal insufficiency, extensive comorbidities, or low-grade, low-stage disease may benefit from endoscopic management. The goals of treating ureteral strictures are ruling out malignancy, preserving renal function, and relieving symptoms. Herein, we present our step-by-step surgical approach to the endoscopic treatment of upper tract urothelial carcinoma and ureteral stricture disease, including surgical technique, pre- and postoperative considerations, instrumentation, and potential complications.


Transitional Cell Carcinoma Distal Ureter Ureteral Stricture Urothelial Tumor Ureteral Access Sheath 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Charbit L, Gendreau M, Mee S, Cukier J. Tumors of the upper urinary tract: 10 years of experience. J Urol. 1991;146(5):1243–6.PubMedGoogle Scholar
  2. 2.
    Huben R, Mounzer A, Murphy G. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer. 1988;62(9):2016–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Williams C, Mitchell J. Carcinoma of the ureter—a review of 54 cases. Br J Urol. 1973;45(4):377–87.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen G, Bagley D. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol. 2000;164(4): 1173–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Elliott D, Segura J, Lightner D, Patterson D, Blute M. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. J Urol. 2001;58(2):174–8.CrossRefGoogle Scholar
  6. 6.
    Kuo RL, Aslan P, Fitzgerald KB, Preminger GM. Use of ureteroscopy and holmium:Yag laser in patients with bleeding diatheses. J Urol. 1998;52(4):609–13.CrossRefGoogle Scholar
  7. 7.
    Wolf JS, Bennett CJ, Dmochowski RR, Pearle MS, Schaeffer AJ. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179(4):1379–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Auge B, Pietrow P, Lallas C, Raj G, Santa-Cruz R, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004;18(1):33–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Siegel J, Smith A. The ideal ureteral stent for antegrade and retrograde endopyelotomy: what would it be like? J Endourol. 1993;7(2):151–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Meretyk I, Meretyk S, Clayman R. Endopyelotomy: comparison of ureteroscopic retrograde and antegrade percutaneous techniques. J Urol. 1992;148:775–82.PubMedGoogle Scholar
  11. 11.
    Pearle M. Use of ureteral stents after endopyelotomy. J Endourol. 1996;10(2):169–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Andreoni C, Lin H, Olwenty E, et al. Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literature. J Urol. 2004;171(2): 859–69.PubMedCrossRefGoogle Scholar
  13. 13.
    Keeley FJ, Kulp D, Bibbo M, McCue P, Bagley D. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157(1): 33–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Tawfiek E, Bibbo M, Bagley D. Ureteroscopic biopsy: technique and specimen preparation. J Urol. 1997;50(1):117–9.CrossRefGoogle Scholar
  15. 15.
    Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S. Intravesical instillatin of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology. 2002; 59(1):53–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Kerbl K, Chandhoke P, Figenshau R, Stone A, Clayman R. Effect of stent duration on ureteral healing following endoureterotomy in an animal model. J Urol. 1993;150(4):1302–5.PubMedGoogle Scholar
  17. 17.
    Mandhani A, Kapoor R, Zaman W, Kumar A, Bhandari M, Gambhir S. Is a 2-week duration sufficient for stenting in endopyelotomy? J Urol. 2003;169(3):886–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Keeley FJ, Bibbo M, Bagley D. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157(5):1560–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Martinez-Pineiro J, Garcia Matres M, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 1996;156(2):377–85.PubMedCrossRefGoogle Scholar
  20. 20.
    Andonian S, Okeke Z, Smith A. Digitial ureteroscopy: the next step. J Endourol. 2008;22(4):603–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Cauberg E, Mamoualakis C, de la Rosette J, de Reijke T. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol. 2011;29(4):503–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Adam B. Shrewsberry
    • 1
    Email author
  • Daniel J. Canter
    • 1
  • Kenneth Ogan
    • 1
  1. 1.Department of UrologyEmory UniversityAtlantaUSA

Personalised recommendations